Trials / Completed
CompletedNCT06932315
A Study to Evaluate the Safety, Tolerability and Dose-Response Relationship of HRS-9190 in Healthy Subjects
A Study to Evaluate the Safety, Tolerability and Dose-Response Relationship of HRS-9190 in Healthy Adults
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 53 (actual)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
This is a single-center, open-label and dose-escalation study to evaluate the safety, tolerability and dose-response relationship of HRS-9190 in healthy adults.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HRS-9190 for Injection | Subject will receive the HRS-9190 injection at different dose levels. |
Timeline
- Start date
- 2025-04-23
- Primary completion
- 2025-08-13
- Completion
- 2025-08-13
- First posted
- 2025-04-17
- Last updated
- 2026-03-06
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06932315. Inclusion in this directory is not an endorsement.